AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre
ECONOMY & POLICY

AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.
This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.
“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.
The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.
Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.
Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.
In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code